A Phase 2 Open-Label Study of EN3835 In The Treatment of Edematous Fibrosclerotic Panniculopathy
Phase of Trial: Phase II
Latest Information Update: 13 Sep 2019
Price : $35 *
At a glance
- Drugs Collagenase clostridium histolyticum (Primary)
- Indications Cellulite
- Focus Therapeutic Use
- Sponsors Endo Pharmaceuticals
- 10 Sep 2018 Status changed from active, no longer recruiting to completed.
- 24 Jul 2018 Planned End Date changed from 1 Jul 2018 to 1 Sep 2018.
- 24 Jul 2018 Planned primary completion date changed from 1 Jul 2018 to 1 Sep 2018.